Nava Ferdowsi

Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis

Nava Ferdowsi, Molla Huq, Wendy Stevens et al. · Annals of the Rheumatic Diseases · 2019 · 69 citations · Full text

Medicine, Clinical Sciences, Clinical Epidemiology +14

Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden

Kathleen Morrisroe, Wendy Stevens, Joanne Sahhar et al. · Arthritis Research & Therapy · 2019 · 66 citations · Full text

Pharmacy, Pharmacoeconomics, Clinical Epidemiology +14

Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality

Nicolas Richard, Marie Hudson, Mianbo Wang et al. · Lara D. Veeken · 2018 · 62 citations

Medicine, Immunology, Clinical Epidemiology +15

Incidence, Risk Factors, and Outcomes of Cancer in Systemic Sclerosis

Kathleen Morrisroe, Dylan Hansen, Molla Huq et al. · Arthritis Care & Research · 2019 · 56 citations · Full text

Medicine, Biostatistics, Oncology +17

The clinical and economic burden of systemic sclerosis related interstitial lung disease

Kathleen Morrisroe, Wendy Stevens, Joanne Sahhar et al. · Lara D. Veeken · 2019 · 42 citations

Medicine, Internal Medicine, Pharmacoeconomics +17